First‑Line Management of Group A Streptococcal Pharyngitis
Primary Treatment Recommendations (IDSA guideline)
- Penicillin V or amoxicillin administered for 10 days is the preferred regimen for patients without a penicillin allergy because of its narrow spectrum, proven efficacy, safety, low cost, and the fact that penicillin‑resistant GAS has never been documented. 1, 2, 3
- Dosing options (Evidence from Circulation 2009)
| Antibiotic | Dose | Duration | Target population |
|---|---|---|---|
| Penicillin V oral | 250 mg twice daily (children); 500 mg 2–3 times daily (adolescents & adults) | 10 days | Children, adolescents, adults |
| Amoxicillin oral | 50 mg/kg once daily (maximum 1000 mg) | 10 days | Children (once‑daily improves adherence) |
| Benzathine penicillin G IM | Single intramuscular injection (weight‑based dose) | Single dose | Patients unlikely to complete oral therapy or at high risk for rheumatic fever (personal/family history, crowded living, low socioeconomic status) |
Treatment for Penicillin‑Allergic Patients (IDSA guideline)
- The therapeutic approach is dictated by the nature of the allergic reaction. 1, 2
- Non‑anaphylactic penicillin allergy – First‑generation cephalosporins (e.g., cephalexin or cefadroxil) for 10 days. 1, 4
- Anaphylactic‑type hypersensitivity – Use clindamycin for 10 days, clarithromycin for 10 days, or azithromycin for 5 days. 1, 2
Duration and Completion of Therapy (IDSA guideline)
- A full 10‑day course must be completed to achieve maximal pharyngeal eradication of GAS, even though clinical improvement usually occurs within 24–48 hours and patients become non‑contagious after 24 hours of therapy. 1, 4
Antibiotic Selection Principles (IDSA guideline)
- Narrow‑spectrum agents should be strongly preferred over broad‑spectrum antibiotics to minimize selection pressure for resistant organisms. 1, 2
- Although some studies report higher eradication rates with cephalosporins, this advantage is attributed to inadvertent inclusion of GAS carriers in trials rather than true superiority over penicillin. 4
- Broad‑spectrum cephalosporins (e.g., cefaclor, cefuroxime, cefixime, cefdinir, cefpodoxime) should be avoided when narrow‑spectrum options are available because they are more costly and promote resistant flora. 4
Timing of Initiation (IDSA guideline)
- Initiating antibiotic therapy 24–48 hours after presentation to await throat culture results does not increase the risk of rheumatic fever; treatment remains effective when started up to 9 days after symptom onset. 4
- Early diagnosis and treatment shorten the period of infectivity and reduce morbidity, enabling a faster return to normal activities. 4
Management of Streptococcal Pharyngitis in Penicillin‑Allergic Patients
Non‑Anaphylactic Penicillin Allergy
Anaphylactic‑Type Penicillin Allergy
Macrolide Considerations
Cross‑Reactivity and Safety
Contagious Period and Transmission of Streptococcal Pharyngitis
Without Antibiotic Treatment
- Untreated individuals with streptococcal pharyngitis remain contagious for the entire symptomatic period and can transmit Group A Streptococcus to close contacts. 8, 9
- Asymptomatic household contacts of patients with streptococcal pharyngitis frequently harbor Group A Streptococcus (approximately one‑third of households); routine testing or prophylactic treatment of these carriers is not recommended because the disease is self‑limited and prophylaxis has limited efficacy. 8, 9
With Antibiotic Treatment
- Clinical improvement typically occurs within 24–48 hours after starting antibiotics for streptococcal pharyngitis, but this rapid symptom resolution does not immediately correspond to loss of bacterial infectivity. 8, 9